# FDA 483 - Robert S. Call, M.D. - October 19, 2022

Source: https://www.globalkeysolutions.net/records/483/robert-s-call-md/88f0715c-692e-4216-9e15-1febe591bc26

> FDA 483 for Robert S. Call, M.D. on October 19, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Robert S. Call, M.D.
- Inspection Date: 2022-10-19
- Product Type: drugs
- Office Name: Office of Regulatory Affairs
- Summary: An FDA inspection of Robert S. Call, M.D., a clinical investigator in Richmond, VA, revealed significant deficiencies in the conduct of clinical investigations. Observations included failures to follow investigational plans, ensure contemporaneous assessment of lab results, and timely report adverse events. Additionally, the firm failed to maintain adequate and accurate case histories, with missing informed consent forms, source records, and numerous discrepancies between source and electronic data.

## Related Documents

- [483 - 2021-03-25](https://www.globalkeysolutions.net/records/483/robert-s-call-md/d121c180-3a38-410c-a07f-8edf2e0ca861)

## Related Officers

- [Consumer Safety Officer/BIMO Investigator](https://www.globalkeysolutions.net/people/david-l-chon/227b9c21-14c4-442b-bdc3-ad167567fd92)

Company: https://www.globalkeysolutions.net/companies/robert-s-call-md/ff9844fc-3148-4764-8217-f077121ae86e

Office: https://www.globalkeysolutions.net/offices/office-of-regulatory-affairs/ff91c598-cf72-4dbe-a2c8-7519c64cbc64